NeuroSense Therapeutics L... (NRSN)
1.03
0.00 (0.00%)
At close: Jan 15, 2025, 1:26 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 2.64M | 3.54M | 11.06M | 699.00K | 895.00K |
| Short-Term Investments | n/a | 3.55M | n/a | n/a | n/a |
| Long-Term Investments | 22.00K | 23.00K | n/a | 37.00K | 35.00K |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a |
| Receivables | 166.00K | 131.00K | 178.00K | 30.00K | 18.00K |
| Inventory | n/a | -3.68M | -178.00K | -67 | -18 |
| Other Current Assets | 110.00K | 160.00K | 171.00K | n/a | n/a |
| Total Current Assets | 2.92M | 7.38M | 11.41M | 729.00K | 913.00K |
| Property-Plant & Equipment | 238.00K | 306.00K | 19.00K | 13.00K | 7.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 260.00K | 329.00K | 19.00K | 50.00K | 42.00K |
| Total Assets | 3.18M | 7.71M | 11.43M | 779.00K | 955.00K |
| Account Payables | 1.46M | 498.00K | 39.00K | 55.00K | 23.00K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 69.00K | 64.00K | n/a | n/a | n/a |
| Other Current Liabilities | 1.93M | 1.16M | 558.00K | 65.00K | 14.00K |
| Total Current Liabilities | 3.46M | 1.73M | 597.00K | 120.00K | 37.00K |
| Long-Term Debt | 73.00K | 294.00K | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.52M | 71.00K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 1.59M | 365.00K | 1.83M | n/a | n/a |
| Total Liabilities | 5.05M | 2.09M | 2.42M | 120.00K | 37.00K |
| Total Debt | 142.00K | 211.00K | 1.83M | n/a | n/a |
| Common Stock | n/a | n/a | n/a | 1K | 1K |
| Retained Earnings | -32.07M | -20.79M | -8.45M | -4.41M | -1.58M |
| Comprehensive Income | n/a | 26.41M | 17.45M | 5.06M | 2.49M |
| Shareholders Equity | -1.87M | 5.62M | 9.01M | 659.00K | 918.00K |
| Total Investments | 22.00K | 3.55M | n/a | 37.00K | 35.00K |